| Richard D Oliver, MD | |
|
22-18 Broadway, Suite 104, Fair Lawn, NJ 07410-1552 | |
| (201) 797-4503 | |
| (201) 797-4270 |
| Full Name | Richard D Oliver |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 47 Years |
| Location | 22-18 Broadway, Fair Lawn, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811081763 | NPI | - | NPPES |
| 2843102 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MA03505200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Valley Home Care Inc. | Paramus, NJ | Home health agency |
| Visiting Health Services Of New Jersey | Totowa, NJ | Home health agency |
| Valley Hospice | Paramus, NJ | Hospice |
| Englewood Hospital And Medical Center | Englewood, NJ | Hospital |
| Valley Hospital | Ridgewood, NJ | Hospital |
| St Joseph's Hospital And Medical Center | Paterson, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Associates Of Englewood Pc | 1355512252 | 519 |
News Archive
A new coating for urinary catheters could reduce the risk of infection, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.
Essentialis, Inc. announced today that the company has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for a Phase 3 efficacy study required for product registration for its product candidate, Diazoxide Choline Controlled Release Tablet (DCCR), for the treatment of patients with very high triglycerides.
Biologic therapies developed in the last decade for rheumatoid arthritis are not associated with an increased risk of cancer when compared with traditional treatments for the condition, according to new research from The University of Texas MD Anderson Cancer Center.
A team led by Afsaneh Gaillard (Inserm Unit 1084, Experimental and Clinical Neurosciences Laboratory, University of Poitiers), in collaboration with the Institute of Interdisciplinary Research in Human and Molecular Biology (IRIBHM) in Brussels, has just taken an important step in the area of cell therapy: repairing the cerebral cortex of the adult mouse using a graft of cortical neurons derived from embryonic stem cells.
› Verified 6 days ago
| Entity Name | Christian Health Care Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427047232 PECOS PAC ID: 7618887340 Enrollment ID: O20040426000168 |
News Archive
A new coating for urinary catheters could reduce the risk of infection, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.
Essentialis, Inc. announced today that the company has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for a Phase 3 efficacy study required for product registration for its product candidate, Diazoxide Choline Controlled Release Tablet (DCCR), for the treatment of patients with very high triglycerides.
Biologic therapies developed in the last decade for rheumatoid arthritis are not associated with an increased risk of cancer when compared with traditional treatments for the condition, according to new research from The University of Texas MD Anderson Cancer Center.
A team led by Afsaneh Gaillard (Inserm Unit 1084, Experimental and Clinical Neurosciences Laboratory, University of Poitiers), in collaboration with the Institute of Interdisciplinary Research in Human and Molecular Biology (IRIBHM) in Brussels, has just taken an important step in the area of cell therapy: repairing the cerebral cortex of the adult mouse using a graft of cortical neurons derived from embryonic stem cells.
› Verified 6 days ago
| Entity Name | Medical Associates Of Englewood Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952681918 PECOS PAC ID: 1355512252 Enrollment ID: O20110927000020 |
News Archive
A new coating for urinary catheters could reduce the risk of infection, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.
Essentialis, Inc. announced today that the company has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for a Phase 3 efficacy study required for product registration for its product candidate, Diazoxide Choline Controlled Release Tablet (DCCR), for the treatment of patients with very high triglycerides.
Biologic therapies developed in the last decade for rheumatoid arthritis are not associated with an increased risk of cancer when compared with traditional treatments for the condition, according to new research from The University of Texas MD Anderson Cancer Center.
A team led by Afsaneh Gaillard (Inserm Unit 1084, Experimental and Clinical Neurosciences Laboratory, University of Poitiers), in collaboration with the Institute of Interdisciplinary Research in Human and Molecular Biology (IRIBHM) in Brussels, has just taken an important step in the area of cell therapy: repairing the cerebral cortex of the adult mouse using a graft of cortical neurons derived from embryonic stem cells.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard D Oliver, MD 22-18 Broadway, Suite 104, Fair Lawn, NJ 07410-1552 Ph: (201) 797-4503 | Richard D Oliver, MD 22-18 Broadway, Suite 104, Fair Lawn, NJ 07410-1552 Ph: (201) 797-4503 |
News Archive
A new coating for urinary catheters could reduce the risk of infection, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.
Essentialis, Inc. announced today that the company has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for a Phase 3 efficacy study required for product registration for its product candidate, Diazoxide Choline Controlled Release Tablet (DCCR), for the treatment of patients with very high triglycerides.
Biologic therapies developed in the last decade for rheumatoid arthritis are not associated with an increased risk of cancer when compared with traditional treatments for the condition, according to new research from The University of Texas MD Anderson Cancer Center.
A team led by Afsaneh Gaillard (Inserm Unit 1084, Experimental and Clinical Neurosciences Laboratory, University of Poitiers), in collaboration with the Institute of Interdisciplinary Research in Human and Molecular Biology (IRIBHM) in Brussels, has just taken an important step in the area of cell therapy: repairing the cerebral cortex of the adult mouse using a graft of cortical neurons derived from embryonic stem cells.
› Verified 6 days ago
Dr. Karen Balonze, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 31-00 Broadway, Fair Lawn, NJ 07410 Phone: 201-796-2255 Fax: 201-796-7020 | |
Dr. Ritesh Kalra, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15-01 Broadway Ste 8, Fair Lawn, NJ 07410 Phone: 201-796-8060 Fax: 201-796-8070 | |
Rahul Agarwal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 31-00 Broadway, Fair Lawn, NJ 07410 Phone: 201-268-7415 Fax: 551-455-6780 | |
Dr. Lawrence Joseph Berman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 20-20 Fair Lawn Ave, Fair Lawn, NJ 07410 Phone: 201-703-0202 Fax: 201-703-1231 | |
Dr. Raghunandan S Loganathan, MD, FCCP Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 31-00 Broadway, Fair Lawn, NJ 07410 Phone: 973-777-7377 Fax: 973-777-3806 | |
Dima Yeshou, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12-04 Saddle River Rd, Fair Lawn, NJ 07410 Phone: 201-773-8710 Fax: 201-773-8711 | |
Dr. Christine Aquino, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 31-00 Broadway, Fair Lawn, NJ 07410 Phone: 201-796-2255 Fax: 201-796-7020 |